Search Results
Sep 10, 2026, 08:58 ET FINBOA Taps Monica Danna as VP of Operations to Lead Operations Strengthen Scalability and Accelerate Growth
transitioning into a core focus on operations in 2020. She has developed a niche expertise in combining EOS principles with technical development lifecycles to drive efficiency. She is also an EOS Integrator™ Masterclass certificate holder."High-growth companies need more than a strong strategy,
More news about: FINBOA
Sep 08, 2026, 08:17 ET HBM9378/WIN378, an Ultra-Long-Acting Antibody Targeting TSLP, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study
p=0.033).Dose-dependent mean reductions in FeNO of up to 24 ppb (or -43% change, p=0.006).Reductions in mean blood eosinophil count (EOS) of up to 200 cells/µL (or -51% change, p<0.0001).Near maximal effects seen as early as Week 2 and sustained through Week 24.Notes:
More news about: Harbour BioMed
Sep 08, 2026, 08:00 ET Kelun-Biotech's Partner Windward Bio Announces Positive Phase 2 Results of SKB378/WIN378 in Asthma, and Initiates Phase 3 Study
p=0.033).Dose-dependent mean reductions in FeNO of up to 24 ppb (or -43% change, p=0.006).Reductions in mean blood eosinophil count (EOS) of up to 200 cells/µL (or -51% change, p<0.0001).Near maximal effects seen as early as Week 2 and sustained through Week 24.SKB378/WIN378
More news about: Kelun-Biotech
Sep 03, 2026, 09:00 ET Battery Storage Market Size Projected to Reach $105.96 Billion By 2030
Active Companies from around the markets with current developments this week include: NOMAD Power Solutions, Inc. (Nasdaq: NMAD), Eos Energy Enterprises, Inc. (Nasdaq: EOSE), Powell Industries, Inc. (Nasdaq: POWL), Vertiv Holdings Co (NYSE: VRT), Generac Holdings
More news about: USA News Group
Aug 27, 2026, 09:12 ET ANA Calls on Marketing Industry to "Push Pause & Power Up" for the AI Future
Work and the skills needed as AI reshapes the profession.Leaders and experts from General Motors, Mastercard, The LEGO Group, Duolingo, SAS, eos Products, and others will address AI, changing consumer behavior, and new ways of working.The program includes training in AI agents
More news about: Association of National Advertisers
Aug 26, 2026, 06:47 ET Alebund Pharmaceuticals Announces 2026 Interim Results
Pan-Phosphate Transporter Inhibitor with the Potential to Reshape the Treatment Landscape of HyperphosphatemiaAP306 (formerly known as EOS789, originally discovered by Chugai) is an oral pan-phosphate transporter inhibitor that simultaneously inhibits three key sodium-dependent intestinal
More news about: Alebund Pharmaceuticals
Aug 26, 2026, 06:44 ET 禮邦醫藥發佈 2026 年中期業績
年獲批，惟須視乎監管審評的進展而定。全球 III 期多區域臨床試驗預計於 2027 年第二季度完成，其後公司計劃向 FDA 遞交新藥上市申請。AP306：同類首創口服泛磷轉運蛋白抑制劑，有望改變高磷血症治療格局AP306（前稱 EOS789，最初由日本中外製藥開發） 是一款口服泛磷轉運蛋白抑制劑，同時抑制三個關鍵的鈉依賴性腸道磷酸鹽轉運蛋白——磷酸鹽轉運蛋白 IIb（NaPi-IIb）、磷酸鹽轉運蛋白 1（PiT-1）及磷酸鹽轉運蛋白 2（PiT-2）。截至最後可行日期（2026 年 8 月 20 日），AP306 為全球首個且唯一進入臨床開發階段的泛磷轉運蛋白抑制劑，亦是唯一同時靶向上述三個關鍵腸道磷轉運蛋白的口服藥物。進行中的全球 IIb
More news about: 禮邦醫藥
Aug 24, 2026, 09:05 ET WATTMORE and Eos Energy Enterprises Announce Strategic Software and Energy Storage Agreement
with Eos' Z3 long-duration energy storage systems. As part of this agreement, Eos has committed to deploy WATTMORE's Intellect Operate Energy Management System (EMS) and Power Plant Controller (PPC) for select customer projects and support integration of WATTMORE's EMS platform with Eos' DawnOS™
More news about: WATTMORE
Aug 13, 2026, 08:15 ET Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger
Agreement") and plan of merger (the "Merger") with Eos SENOLYTIX, Inc. ("Eos"). The proposed Merger is currently anticipated to close in the third quarter of 2026, subject to customary closing conditions. If the proposed Merger is completed, the business of Eos will continue as the business of the combined
More news about: Pulmatrix Inc.
Aug 11, 2026, 06:11 ET 50/50 Women on Boards™ Announces its 2026 Global Summit Speakers
ValueLori Keith, Portfolio Manager, Parnassus Investments; Board Member, e.l.f. BeautyDiana Glassman, Stewardship Director, EOS at Federated Hermes Ltd; Board Member, Helix Energy SolutionsThe Global Debate: Public Trust — When Should Boards Speak?
More news about: 50/50 Women on Boards
Aug 10, 2026, 09:26 ET Kuehn Law Encourages Investors of Eos Energy Enterprises, Inc. to Contact Law Firm
10, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Eos Energy Enterprises, Inc. (NASDAQ: EOSE) breached their fiduciary duties to shareholders.
More news about: Kuehn Law, PLLC
Aug 05, 2026, 10:31 ET Hyperphosphatemia Market Set for Robust Growth During the Forecast Period (2026-2036), Driven by Novel Therapeutics and Rising CKD Burden | DelveInsight
inhibits the active transport of phosphate, making it the only investigational therapy with this mechanism of action for CKD.Formerly known as EOS789, AP306 was initially discovered and advanced by Chugai Pharmaceutical Co., Ltd. before being licensed to Alebund Pharmaceuticals. The therapy is currently
More news about: DelveInsight Business Research, LLP
Aug 04, 2026, 11:00 ET AKA Launches 'EOS' Sales Knowledge Engine Globally, Now Available on AWS Marketplace
AKA, an AI business solutions company, today announced the global launch of EOS, a Sales Knowledge Engine that verifies and certifies the factual product knowledge of customer-facing teams. Alongside the launch, EOS is now listed on the Amazon Web Services (AWS) Marketplace, enabling enterprises
More news about: AKA
Aug 03, 2026, 17:56 ET TETRA TECHNOLOGIES, INC. REPORTS STRONG SECOND-QUARTER 2026 RESULTS
continue to grow at a rate exceeding GDP. New markets for U.S. semiconductor chip manufacturing are also driving incremental revenue opportunities. Eos continues to ramp its manufacturing capacity and has set a year-end goal of 4 GWh of capacity before the end of 2026. This would represent a step change
More news about: TETRA Technologies, Inc.
Jul 31, 2026, 09:00 ET EOS BUILDS ON ITS LIP CARE LEADERSHIP WITH LAUNCH OF DEWY LIP SHINE
Soyoung Kang, President of eos. "With Dewy Lip Shine, we created a formula that puts care first without compromising color or shine. It's everything our community loves about eos—sensorial, high-performing and approachable—reimagined in a completely new format."Powered by eos' signature Cashmere Smooth™
More news about: eos Products
Jul 30, 2026, 16:05 ET DIAMONDROCK HOSPITALITY COMPANY REPORTS SECOND QUARTER 2026 RESULTS
-EOS HospitalityAt will with no fee
More news about: DiamondRock Hospitality Company
Jul 27, 2026, 11:27 ET The ADVERTISING Club of New York Names Five New Board Members and Recognizes Exceptional Volunteerism
Lori Goode, CMO, Index ExchangeEllen Griffin, Global President, OMD WorldwideEllen Hawes, SVP, Omnichannel & Strategy, eosAaron Sobol, Head of NA Media Investment and Data Governance, Unilever Carlos Zepeda, SVP, Strategy & Marketing, Wine
More news about: The ADVERTISING Club of New York
Jul 21, 2026, 09:31 ET WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.
Company's Pharmacy and Pharmacy Services division as Corexa Health; the Company's proposed transaction with DataVault AI Inc., Scilex Holding Company, EOS Holdings and HealthBridge Advisors; the anticipated timing, structure, terms and completion of such transaction; the satisfaction or waiver of closing
More news about: DataMeds AI, Inc.
Jul 21, 2026, 08:50 ET Angel Yeast's Initiative Advances Internationally Recognized Codex Standard for baker's yeast
successfully registered China's National Standard for Yeast Extract (GB/T 23530-2009) with the Egyptian Organization for Standardization and Quality (EOS), where it received official recognition, introducing the standard into the African market."We are proud to have contributed to the development
More news about: Angel Yeast
Jul 21, 2026, 07:00 ET Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase IIb Multi-Regional Clinical Trial of AP306 for Hyperphosphatemia
multiple clinical sites in the United States and China and is co-sponsored by Alebund and R1 Therapeutics, Inc. ("R1"). AP306 (formerly known as EOS789) is a first-in-class oral pan-phosphate transporter inhibitor. AP306 was originally discovered and developed by Chugai Pharmaceutical Co., Ltd. ("Chugai")
More news about: Alebund Pharmaceuticals
Jul 20, 2026, 08:35 ET Tom Ruggie Earns Back-to-Back InvestmentNews Advisor of the Year Honors for Alternative Investments
experience, continuous learning, and collaboration with some of the world's leading thought leaders through organizations including Strategic Coach, Vistage, EOS and TIGER 21.About InvestmentNews Published by Key Media, InvestmentNews provides investment news and analysis,
More news about: Destiny Family Office
Jul 16, 2026, 10:15 ET 3D Printing Market worth $31.77 billion by 2032 - Exclusive Report by MarketsandMarkets™
3D printing companies are Stratasys (US); EOS GmbH (Belgium); HP Development Company, L.P. (US); 3D Systems, Inc. (US); GE Aerospace (US); Materialise (Belgium); Nano Dimension (US); voxeljet AG
More news about: MarketsandMarkets
Jul 15, 2026, 08:00 ET Rambam Health Care Campus, EOS and PTC Partner to Establish Advanced In-House Digital Implant Engineering Center
not only to their patients, but to the wider global community.About EOS: EOS provides responsible manufacturing solutions via industrial 3D printing technologies to organizations around the world. Since 1989, EOS has shaped the future of manufacturing by enabling its customers to innovate
More news about: PTC Inc.
Jul 13, 2026, 16:01 ET Canon EOS C300 Mark III Digital Cinema Camera, Instant Savings Now Available at B&H Photo Video
EOS C300 Mark III supports a wide variety of professional workflows with advanced recording options, high frame rate capabilities, and compatibility with Canon's renowned Cinema EOS ecosystem. Whether capturing documentaries, commercials, live
More news about: B&H Photo
Jul 10, 2026, 13:38 ET SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--PULM, SLP, OLN, and HUN
PULM) related to its merger with Eos SENOLYTIX, Inc. Upon closing of the proposed transaction, Pulmatrix shareholders are expected to own approximately 6% of the combined company.Click
More news about: Monteverde & Associates PC